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断技术主要有 CT（计算机 X 射线断层扫描技术），X 线透射检查，MRI（核磁共







































Medical imageology is playing a more and more important role in clinical 
diagnosis and scientific research,especially the cilinical diagnosis, the imaging 
diagnosis is irreplaceable.The mainly imaging diagnosis procedure concludes the 
following four techniques: CT(ComputedTomography),X-ray transmission 
check,MRI(Magnetic Resonance Imaging) and Ultrasonic Inspection. Among the 
foure kinds of diagnosis procedure,the CT and the X-ray transmission check is widely 
used in angiography, urinary imaging,spinal cord angiography and so on.However, the 
powerful transmission function of the X ray makes it hard to identify the tiny 
difference of diseased tissue and ordinary tissue,for example the  difference of 
angioma and the blood vessel is hard to tell in the X-ray image,for this reason we need 
a kind of drug that can enhance the contrast radio of the image,and the drug is what 
we call contrast media. 
Contrast media is a kind of drug used in clinical imaging diagnosis to strengthen 
the contrast radio and make the image more clear to identify. The most popular 
contrast media used in clinical diagnosis is the nonionic contrast media based on the 
triiodinebenzene backbone. The dimer triiodinebenzene backbone contrast media is 
better used in clinical diagnosis,  but due to the complicated manufacture procedure, 
its cost is so high that the operating frequency is limited in practice. We synthesized 
five new kind of contrast media based on the structure-function relationship 
information and one of them contains phosphorus group in the molecule.We 
investigate the efficiency of imaging diagnosis of the five contrast media compared to 
two commercial available contrast media Iohexol and Ioversol. The result suggests 
there is no significant difference between the five compounds we synthesized and two 
commercial contrast media. But the produce route designed for the five compounds is 
more reasonable and suitable for industial manufacture.The synthsis starts from 
5-aminoisophthalic and the final compound is obtained after six steps.All the 
intermediate needs no purification and can be crystallized from the reaction as the 
starting material of the next produce step.Besides,we optimized produce conditions of 
a widely used dimer contrast media-Iodixanol in cooperation with pharmaceutical 
factory.We combined the chromatographic purification and non-chromatographic 
















isolatedby XAD1600 resin to purity of 85% and then crystalline in butanol to purity 
of 99%.The final product we get can fully meet the require of the pharmacopeia 
standard. 
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这张著名的伦琴夫人手的 X 线照片，是第一张 X 线照片。图里可以清楚看
出，密度较大的骨骼和周围密度较小的软组织的清楚对比，然而，周围软组织间
的对比度却小到难以分辨。因此，为了区分出像心血管系统这样的软组织，需要
使用一种安全性好，能有效提高 X 线成像对比度的药物，我们称之为造影剂。 
1.2 造影剂的应用 





















了具有连续波长的 X 射线[1]。 




I 为透过的 X 线强度，I0 为 X 线初始强度，μ 为穿透物质的质量衰减系数，
X 为穿透物质的厚度[2] 
 





























1.2.2 X 线造影剂的分类 



















透压（1500-2100 mOsm/KgH2O）是血浆渗透压的 5-7 倍，低渗型造影剂如非离
子型单体造影剂碘海醇、碘帕醇等，等渗型如碘克沙醇、碘曲仑等。 
1.2.3 X 线造影剂的临床应用 
X 线造影剂主要用于临床影像诊断当中。由于人眼无法识别 X 线，因此必
须将 X 线成像信息转化为可读信号，根据成像信息转化手段的不同可以将目前
主要的 X 线诊断手段分为四种：X 线摄影术、X 线荧光成像术、计算机体层扫
描术（CT）和数字减影血管造影术（DSA），其中以 CT 和 X 线摄影术使用比例





















   次硝酸铋或许是第一个普遍用于人体的金属类造影剂。1897 年，用 5%的次硝
酸铋悬浮液获得的一段胃肠道造影图片是铋用来造影的第一张照片，1898 年，
铋餐或糖浆剂就用来做胃肠道整段造影[6]。 
1905 年，胶体银也曾用作尿路造影。随后银的无机盐如 AgI 和 Ag2O 也用来
做肾盂造影，但是由于严重的副作用这种银类造影剂很快被禁用[7]。 









 十九世纪六十年代末期颗粒尺寸 2.5-5mm 的钽粉末，平均尺寸 7.2mm 的钨粉末
和 5-6mm 的钨酸钙粉末曾被用作支气管造影[12]。 




上看，配体又分线形分子和环形分子，线形配体以 EDTA 和 DTPA 及其衍生物为
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